Barclays’s Sensus Healthcare SRTS Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTS
Barclays's SRTS Position: Q3 2026 in Review
Barclays increased its Sensus Healthcare (SRTS) stake by 23% in Q3 2026, buying an estimated $2.02K and bringing the position to 3,440 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4831.
Barclays first reported a position in SRTS in Q3 2018 and has held it in 12 quarters since. The position peaked at $46.9K in Q4 2022. 37 funds tracked by Wall St. Rank hold SRTS as of Q3 2026.
- Barclays held 3,440 shares of Sensus Healthcare worth $10.3K as of Q3 2026.
- Barclays bought 654 Sensus Healthcare shares in Q3 2026, an estimated $2.02K.
- Sensus Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4831 holding.
- Barclays first reported a position in Sensus Healthcare in Q3 2018 and has held it in 12 quarters since.
- Barclays's Sensus Healthcare position peaked at $46.9K in Q4 2022.
- 37 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.